Patti Gilliano’s COVID-19 symptoms began in August, 2020. She had read about ivermectin’s ability to treat the disease, so when she went to the hospital because she began to have breathing difficulties, she asked the doctor to prescribe ivermectin for her.

FLCCC Alliance Applauds International Group of Medical Experts’ Recognition of Ivermectin as a Safe and Effective Treatment for COVID-19

The FLCCC Alliance is troubled by the recently updated consumer guidance on Ivermectin from the FDA. The guidance from the FDA is misleading and has the potential to raise unwarranted concern over an important drug in the prevention and treatment of COVID-19.

Weekly Update March 3, 2021 featuring data analyst Juan Chamie and his insightful charts and graphs focused on ivermectin in South America.

Dr. Tess Lawrie, Director of the Evidence-based Medicine Consultancy in Bath, England, and a regular consultant to the WHO, on whether more Randomized Controlled Trials are needed for Ivermectin in COVID-19

Can Ivermectin Be Used to Treat COVID-19? Pulmonary and critical care specialist Dr. Pierre Kory appeared on The Doctors television show, which aired on February 8, 2021, to discuss whether ivermectin, which has been used for 40 years to treat head lice and many parasitic diseases, can be used to treat COVID-19.

Merck’s assessments of ivermectin’s efficacy in COVID-19 are in striking contrast with the findings reported by multiple expert group’s systematic reviews from across the globe.

The Efficacy of Ivermectin Against COVID‑19 is a lecture Dr Pierre Kory gave hosted by YPO Gold’s Southern California Chapter for hundreds of CEOs within the network internationally.

On January 6, 2021, Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line Covid-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data on ivermectin before the National Institutes of Health (NIH) Treatment Guidelines Panel.

Martin D. Hellwig a, Anabela Maia b https://doi.org/10.1016/j.ijantimicag.2020.106248 Abstract As COVID-19 (coronavirus disease 2019) continues to rapidly spread throughout the world, the incidence varies greatly among different countries. These differences raise the question whether nations with a lower incidence share any medical commonalities that could be used not only to explain that lower incidence [...]